Researchers discover resistance mechanism to checkpoint inhibitors and how to reverse it

(European Society for Medical Oncology) Researchers have discovered a mechanism of resistance to checkpoint inhibitors and how to reverse it. The biomarker results from the IMvigor210 study are reported at the ESMO Immuno Oncology Congress 2017.